Cannabis Expert Tim Seymour's Favorite Pot Stocks And ETF
Zacks Investment Research | Aug 12, 2019 04:47AM ET
- (0:50) - Why Should Investors Consider Investing In The Cannabis Industry?
- (7:00) - Tim Seymour’s Background In The Cannabis Market
- (14:15) - What Is The Growth Potential and What Will Drive It?
- (20:45) - Medical vs Recreational: What Stands To Benefit The Most?
- (27:50) - Can We Expect Federal Legal Changes Anytime Soon?
- (33:05) - Amplify Seymour Cannabis ETF: CNBS
- (44:40) - Breaking Down CNBS Top Holdings
- (49:50) - Risks and Areas To Be Cautious Of Within The Cannabis Industry
- (55:00) - How Can Investors Benefit From Thematic Investing?
- Podcast@Zacks.com
In this episode of ETF Spotlight, I speak with Tim Seymour, founder & CIO of Seymour Asset Management and co-host of CNBC's Fast Money, and Christian Magoon, founder & CEO of Amplify ETFs.
We discuss cannabis investing and the Amplify Seymour Cannabis ETF CNBS , which is actively managed by Tim.
We start with the investment case for cannabis--why investors should consider marijuana stocks and ETFs. Per Amplify, global legal cannabis sales have risen approximately 30% per year recently, with 2019 sales expected to grow 39% from 2018.
Tim is an early stage cannabis investor and also serves as a board member for several private cannabis companies. What drew him to the cannabis industry?
Recreational marijuana use is now legal in 11 states and Washington D.C. and medical marijuana use is legal in 33 states, but it remains illegal at the federal level. We discuss the current regulatory landscape, rising support for legalizing cannabis and recent legislative developments.
CNBS invests in marijuana companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem. Its top holdings include Canopy Growth (NYSE:CGC) Aurora Cannabis (TSX:ACB) , GW Pharmaceuticals (NASDAQ:GWPH) MediPharm Labs, Organigram Holdings (NASDAQ:OGI) Village Farms International (TSX:VFF) and Canaccord Genuity.
Tim talks about some of his favorite cannabis stocks.
There are four more pot ETFs available to investors now--the ETFMG Alternative Harvest ETF (CSE:MJ) , the AdvisorShares Pure Cannabis ETF (LON:YOLO) , The Cannabis ETF TOKE . How is CNBS different from other pot ETFs?
Are there any pot stocks investors should stay away from? CannTrust Holdings (NYSE:CTST) has lost more than 50% of its value since it disclosed a serious regulatory breach on July 8. What else do investors need to know?
Amplify has a number of ETFs focused on disruptive themes, like the Amplify Online Retail ETF IBUY . We talk about the role of thematic ETFs in investors’ portfolios.
Get The News You Want
Please visit AmplifyETF.com to learn more about CNBS and other Amplify ETFs.
Make sure to be on the lookout for the next edition of ETF Spotlight! If you have any comments or questions, please email podcast@zacks.com.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.